Skip to main content
SpringerLink
Log in

Special Considerations in Management of Jugular Paraganglioma

  • Chapter
  • First Online:
Contemporary Management of Jugular Paraganglioma

  • 434 Accesses

Abstract

Paragangliomas are neuroendocrine neoplasms that arise from chief cells in extra-adrenal paraganglia of the peripheral nervous system. While previous chapters have expanded upon historical, diagnostic, and management issues pertaining to paragangliomas, this chapter will discuss the management and prognosis regarding multicentric paragangliomas, malignant tumors, catecholamine-secreting paragangliomas, high-risk anesthetic patients, and future directions. Due to the paucity of literature on these particular topics, studies analyzing other head and neck paragangliomas, as well as non-head and neck paragangliomas and pheochromocytomas, are reviewed when relevant to highlight special considerations in management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Szymanska A, Szymanski M, Czekajska-Chehab E, Golabek W, Szczerbo-Trojanowska M. Diagnosis and management of multiple paragangliomas of the head and neck. Eur Arch Otorhinolaryngol. 2015;272(8):1991–9.

    Article  PubMed  Google Scholar 

  2. Al-Mefty O, Teixeira A. Complex tumors of the glomus jugulare: criteria, treatment, and outcome. J Neurosurg. 2002;97(6):1356–66.

    Article  PubMed  Google Scholar 

  3. Myssiorek D, Ferlito A, Silver CE, et al. Screening for familial paragangliomas. Oral Oncol. 2008;44(6):532–7.

    Article  CAS  PubMed  Google Scholar 

  4. Burnichon N, Abermil N, Buffet A, Favier J, Gimenez-Roqueplo AP. The genetics of paragangliomas. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129(6):315–8.

    Article  CAS  PubMed  Google Scholar 

  5. van der Mey AG, Frijns JH, Cornelisse CJ, et al. Does intervention improve the natural course of glomus tumors? A series of 108 patients seen in a 32-year period. Ann Otol Rhinol Laryngol. 1992;101(8):635–42.

    Article  PubMed  Google Scholar 

  6. Piazza P, Di Lella F, Menozzi R, Bacciu A, Sanna M. Absence of the contralateral internal carotid artery: a challenge for management of ipsilateral glomus jugulare and glomus vagale tumors. Laryngoscope. 2007;117(8):1333–7.

    Article  PubMed  Google Scholar 

  7. Elshaikh MA, Mahmoud-Ahmed AS, Kinney SE, et al. Recurrent head-and-neck chemodectomas: a comparison of surgical and radiotherapeutic results. Int J Radiat Oncol Biol Phys. 2002;52(4):953–6.

    Article  PubMed  Google Scholar 

  8. Wanna GB, Sweeney AD, Carlson ML, et al. Subtotal resection for management of large jugular paragangliomas with functional lower cranial nerves. Otolaryngol Head Neck Surg. 2014;151(6):991–5.

    Article  PubMed  Google Scholar 

  9. Sanna M, Jain Y, De Donato G, Rohit LL, Taibah A. Management of jugular paragangliomas: the Gruppo Otologico experience. Otol Neurotol. 2004;25(5):797–804.

    Article  PubMed  Google Scholar 

  10. Lattes R, Waltner JG. Nonchromaffin paraganglioma of the middle ear; carotid-body-like tumor; glomus-jugulare tumor. Cancer. 1949;2(3):447–68.

    Article  CAS  PubMed  Google Scholar 

  11. Brewis C, Bottrill ID, Wharton SB, Moffat DA. Metastases from glomus jugulare tumours. J Laryngol Otol. 2000;114(1):17–23.

    CAS  PubMed  Google Scholar 

  12. Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002;94(3):730–7.

    Article  PubMed  Google Scholar 

  13. Manolidis S, Shohet JA, Jackson CG, Glasscock ME 3rd. Malignant glomus tumors. Laryngoscope. 1999;109(1):30–4.

    Article  CAS  PubMed  Google Scholar 

  14. Yetiser S, Ramadan S. Multiple primary malignant paraganglioma of the head and neck with lymph node metastasis. Kulak Burun Bogaz Ihtis Derg. 2015;25(4):232–6.

    Article  PubMed  Google Scholar 

  15. Lack EE, Armed Forces Institute of Pathology (U.S.). Tumors of the adrenal glands and extraadrenal paraganglia. Washington, DC: American Registry of Pathology: Armed Forces Institute of Pathology; 2007.

    Google Scholar 

  16. Eisenhofer G, Lenders JW, Siegert G, et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer. 2012;48(11):1739–49.

    Article  CAS  PubMed  Google Scholar 

  17. Chapman DB, Lippert D, Geer CP, et al. Clinical, histopathologic, and radiographic indicators of malignancy in head and neck paragangliomas. Otolaryngol Head Neck Surg. 2010;143(4):531–7.

    Article  PubMed  Google Scholar 

  18. Shyam Kumar S, Thakar A. Complex glomus jugulare tumor: management issues. Indian J Otolaryngol Head Neck Surg. 2013;65(Suppl 3):676–81.

    Article  CAS  PubMed  Google Scholar 

  19. Remine WH, Chong GC, Van Heerden JA, Sheps SG, Harrison EG Jr. Current management of pheochromocytoma. Ann Surg. 1974;179(5):740–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Linnoila RI, Lack EE, Steinberg SM, Keiser HR. Decreased expression of neuropeptides in malignant paragangliomas: an immunohistochemical study. Hum Pathol. 1988;19(1):41–50.

    Article  CAS  PubMed  Google Scholar 

  21. Mediouni A, Ammari S, Wassef M, et al. Malignant head/neck paragangliomas. Comparative study. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131(3):159–66.

    Article  CAS  PubMed  Google Scholar 

  22. Hoegerle S, Ghanem N, Altehoefer C, et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging. 2003;30(5):689–94.

    Article  CAS  PubMed  Google Scholar 

  23. Spetz J, Dalmo J, Nilsson O, Wangberg B, Ahlman H, Forssell-Aronsson E. Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy. Horm Metab Res. 2012;44(5):400–4.

    Article  CAS  PubMed  Google Scholar 

  24. Massey V, Wallner K. Treatment of metastatic chemodectoma. Cancer. 1992;69(3):790–2.

    Article  CAS  PubMed  Google Scholar 

  25. Plouin PF, Fitzgerald P, Rich T, et al. Metastatic pheochromocytoma and paraganglioma: focus on therapeutics. Horm Metab Res. 2012;44(5):390–9.

    Article  CAS  PubMed  Google Scholar 

  26. Daramola OO, Shinners MJ, Levine SC. Secreting jugulotympanic paraganglioma with venous involvement into the thorax. Laryngoscope. 2008;118(7):1233–5.

    Article  PubMed  Google Scholar 

  27. Teranishi Y, Kohno M, Sora S, Sato H, Haruyama N. Perioperative management of catecholamine-secreting glomus jugulare tumors. J Neurol Surg Rep. 2014;75(1):e170–4.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Colen TY, Mihm FG, Mason TP, Roberson JB. Catecholamine-secreting paragangliomas: recent progress in diagnosis and perioperative management. Skull Base. 2009;19(6):377–85.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Goutcher CM, Cossar DF, Ratnasabapathy U, Burke AM. Magnesium in the management of catecholamine-secreting glomus tumours with intracranial extension. Can J Anaesth. 2006;53(3):316–21.

    Article  PubMed  Google Scholar 

  30. Pandya SK, Nagpal RD, Desai AP, Purohit AV. Death following external carotid artery embolization for a functioning glomus jugulare chemodectoma. Case report. J Neurosurg. 1978;48(6):1030–4.

    Article  CAS  PubMed  Google Scholar 

  31. Matishak MZ, Symon L, Cheeseman A, Pamphlett R. Catecholamine-secreting paragangliomas of the base of the skull. Report of two cases. J Neurosurg. 1987;66(4):604–8.

    Article  CAS  PubMed  Google Scholar 

  32. Fussey JM, Kemeny AA, Sankar S, Rejali D. Successful management of a catecholamine-secreting glomus jugulare tumor with radiosurgery alone. J Neurol Surg Part B, Skull Base. 2013;74(6):399–402.

    Article  Google Scholar 

  33. Castrucci WA, Chiang VL, Hulinsky I, Knisely JP. Biochemical and clinical responses after treatment of a catecholamine-secreting glomus jugulare tumor with gamma knife radiosurgery. Head Neck. 2010;32(12):1720–7.

    Article  PubMed  Google Scholar 

  34. Mittal S, Monsell EM, Narayanan S, Kupsky WJ, Guthikonda M, Mittal S. Synchronous occurrence of paraganglioma of the glomus jugulare and olfactory groove meningioma. Clin Neuropathol. 2013;32(4):328–31.

    Article  PubMed  Google Scholar 

  35. Fukusumi A, Kobayashi Y, Iwasaki T, et al. An unusual case of glomus jugulare tumor accompanied with meningioma. Rinsho Hoshasen. 1983;28(6):685–8.

    CAS  PubMed  Google Scholar 

  36. Tokunaga T, Shigemori M, Hirohata M, Sugita Y, Miyagi J, Kuramoto S. Multiple primary brain tumors of different histological types—report of two cases. Neurol Med Chir (Tokyo). 1991;31(3):141–5.

    Article  CAS  Google Scholar 

  37. Dario A, Scamoni C, Cerati M, Marra A, Dorizzi A. Associated olfactory groove meningioma and acoustic neurinoma. Tumori. 1996;82(4):405–7.

    CAS  PubMed  Google Scholar 

  38. Reubi JC, Laissue J, Krenning E, Lamberts SW. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol. 1992;43(1–3):27–35.

    Article  CAS  PubMed  Google Scholar 

  39. Rafferty MA, Walsh RM, Walsh MA. Somatostatin therapy for glomus tumors: a report of two cases. Skull Base. 2002;12(2):53–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kau R, Arnold W. Somatostatin receptor scintigraphy and therapy of neuroendocrine (APUD) tumors of the head and neck. Acta Otolaryngol. 1996;116(2):345–9.

    Article  CAS  PubMed  Google Scholar 

  41. Duet M, Guichard JP, Rizzo N, Boudiaf M, Herman P, Tran Ba Huy P. Are somatostatin analogs therapeutic alternatives in the management of head and neck paragangliomas? Laryngoscope. 2005;115(8):1381–4.

    Article  CAS  PubMed  Google Scholar 

  42. Gonias S, Goldsby R, Matthay KK, et al. Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma. J Clin Oncol. 2009;27(25):4162–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Joshua AM, Ezzat S, Asa SL, et al. Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma. J Clin Endocrinol Metab. 2009;94(1):5–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology-Head and Neck Surgery, University Texas Southwestern, Dallas, TX, USA

    Jacob B. Hunter M.D.

Authors
  1. Jacob B. Hunter M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob B. Hunter M.D. .

Editor information

Editors and Affiliations

  1. Department of Otolaryngology, Mount Sinai Health System, New York, New York, USA

    George B. Wanna

  2. Department of Otolaryngology, Mayo Clinic School of Medicine, Rochester, New York, USA

    Matthew L. Carlson

  3. Center for Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    James L. Netterville

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Hunter, J.B. (2018). Special Considerations in Management of Jugular Paraganglioma. In: Wanna, G., Carlson, M., Netterville, J. (eds) Contemporary Management of Jugular Paraganglioma. Springer, Cham. https://doi.org/10.1007/978-3-319-60955-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60955-3_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-60954-6

  • Online ISBN: 978-3-319-60955-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation